Company: BIVIW
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001520138-25-000205
Chunk: 5

Company: BIOVIE INC.
Filing Date: 2025-07-11
Form: S-1/A
Chunk 5
---
 Experts                                                                               |  86 |
| Where You Can Find More Information                                                   |  86 |
| Index to Financial Statements                                                         | F-1 |

<div align='center'>ABOUT THIS PROSPECTUS</div>

The registration statement we filed with the Securities
and Exchange Commission (the “SEC”) includes exhibits that provide more detail of the matters discussed in this prospectus.
You should read this prospectus and the related exhibits filed with the SEC before making your investment decision. You should rely only
on the information provided in this prospectus. You should not assume that the information contained in this prospectus or any related
free writing prospectus is accurate on any date subsequent to the date set forth on the front of the document, even though this prospectus
or any related free writing prospectus is delivered, or securities are sold, on a later date. This prospectus contains or incorporates
by reference summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual
documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the
documents referred to herein have been or will be filed, and you may obtain copies of those documents as described in this prospectus
supplement under the heading “Where You Can Find More Information.”

You should rely only on the information that we have included in this prospectus and any related free writing prospectus that we may authorize to be provided to you. Neither we, nor the underwriters, have authorized any dealer, salesman or other person to give any information or to make any representation other than those contained in this prospectus or any related free writing prospectus that we may authorize to be provided to you. You must not rely upon any information or representation not contained in this prospectus or any related free writing prospectus. This prospectus and any related free writing prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor does this prospectus or any related free writing prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.

At a special meeting of the Company’s stockholders
held on June 23, 2025, the Company’s stockholders approved a proposal to grant the Board authority, in its sole discretion, prior
to the one-year anniversary of such special